These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3742239)

  • 1. The ontogeny of amphetamine-induced dopamine release in the caudate-putamen of the rat.
    Gazzara RA; Fisher RS; Howard SG
    Brain Res; 1986 Aug; 393(2):213-20. PubMed ID: 3742239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphetamine-induced and spontaneous release of dopamine from A9 and A10 cell dendrites: an in vitro electrophysiological study in the mouse.
    Bernardini GL; Gu X; Viscardi E; German DC
    J Neural Transm Gen Sect; 1991; 84(3):183-93. PubMed ID: 1679335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential release of acetylcholinesterase in vivo, from the guinea pig substantia nigra compared to the caudate putamen following dopamine depletion.
    Dally JJ; Temlett JA; Greenfield SA
    Neuropharmacology; 1996 May; 35(5):579-87. PubMed ID: 8887965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalamic control of dopaminergic functions in the caudate-putamen of the rat--II. Studies using ibotenic acid injection of the parafascicular-intralaminar nuclei.
    Kilpatrick IC; Jones MW; Johnson BJ; Cornwall J; Phillipson OT
    Neuroscience; 1986 Nov; 19(3):979-90. PubMed ID: 3796824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine release induced by electrical stimulation of microdissected caudate-putamen and substantia nigra of the rat brain.
    Aceves J; Cuello AC
    Neuroscience; 1981; 6(10):2069-75. PubMed ID: 7301117
    [No Abstract]   [Full Text] [Related]  

  • 6. Dopaminergic and neostriatal neurons: dose-dependent changes in sensitivity to amphetamine following long-term treatment.
    Kamata K; Rebec GV
    Neuropharmacology; 1983 Dec; 22(12A):1377-82. PubMed ID: 6664466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotensin-induced dopamine release in vivo and in vitro from substantia nigra and nucleus caudate.
    Faggin BM; Zubieta JK; Rezvani AH; Cubeddu LX
    J Pharmacol Exp Ther; 1990 Feb; 252(2):817-25. PubMed ID: 2138224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects.
    Clausing P; Gough B; Holson RR; Slikker W; Bowyer JF
    J Pharmacol Exp Ther; 1995 Aug; 274(2):614-21. PubMed ID: 7636721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presynaptic and postsynaptic D1 dopamine receptors in the nigrostriatal system of the rat brain: a quantitative autoradiographic study using the selective D1 antagonist [3H]SCH 23390.
    Filloux FM; Wamsley JK; Dawson TM
    Brain Res; 1987 Apr; 408(1-2):205-9. PubMed ID: 2954613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoradiographic localization of neuroleptic and dopamine receptors in the caudate-putamen and substantia nigra: effects of lesions.
    Murrin LC; Gale K; Kuhar MJ
    Eur J Pharmacol; 1979 Dec; 60(2-3):229-35. PubMed ID: 43260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoxetine increases long-lasting neostriatal dopamine depletion after administration of d-methamphetamine and d-amphetamine.
    Ricaurte GA; Fuller RW; Perry KW; Seiden LS; Schuster CR
    Neuropharmacology; 1983 Oct; 22(10):1165-9. PubMed ID: 6606137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
    Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T
    Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of dopamine evoked by electrical stimulation of the motor and visual areas of the cerebral cortex in both caudate nuclei and in the substantia nigra in the cat.
    Nieoullon A; Cheramy A; Glowinski J
    Brain Res; 1978 Apr; 145(1):69-83. PubMed ID: 638784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys.
    Gerhardt GA; Cass WA; Huettl P; Brock S; Zhang Z; Gash DM
    Brain Res; 1999 Jan; 817(1-2):163-71. PubMed ID: 9889359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphetamine-stimulated release of endogenous dopamine from the rat caudate nucleus in vivo.
    Philips SR; Robson AM
    Neurochem Res; 1983 Jun; 8(6):731-41. PubMed ID: 6621771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a direct action of amphetamine on dopamine metabolism in the rat substantia nigra in vivo.
    Argiolas A; Fadda F; Stefanini E; Gessa GL
    Naunyn Schmiedebergs Arch Pharmacol; 1978; 301(3):171-4. PubMed ID: 634376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dopamine agonists and antagonists on DOPA formation in the substantia nigra.
    Argiolas A; Melis MR; Fadda F; Serra G; Gessa GL
    J Neurochem; 1982 Jan; 38(1):75-9. PubMed ID: 6809898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of dopamine in both caudate nuclei and both substantia nigrae in response to unilateral stimulation of cerebellar nuclei in the cat.
    Nieoullon A; Cheramy A; Glowinski J
    Brain Res; 1978 Jun; 148(1):143-52. PubMed ID: 656921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin or dopamine release and uptake in the caudate putamen, nucleus accumbens, substantia nigra pars reticulata, and the dorsal raphé nucleus slices.
    Iravani MM; Asari D; Patel J; Wieczorek WJ; Kruk ZL
    Synapse; 2000 Jun; 36(4):275-85. PubMed ID: 10819905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional differences in evoked dopamine efflux in brain slices of rat anterior and posterior caudate putamen.
    Patel J; Trout SJ; Kruk ZL
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep; 346(3):267-76. PubMed ID: 1407013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.